Search by Drug Name or NDC
NDC 69097-0998-07 Metaxalone 400 mg/1 Details
Metaxalone 400 mg/1
Metaxalone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by CIPLA USA INC.. The primary component is METAXALONE.
MedlinePlus Drug Summary
Metaxalone, a muscle relaxant, is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries.
Related Packages: 69097-0998-07Last Updated: 05/05/2024
MedLinePlus Full Drug Details: Metaxalone
Product Information
| NDC | 69097-0998 |
|---|---|
| Product ID | 69097-998_ab6ad4e1-6b03-45c9-b4d0-59bda8e3b35d |
| Associated GPIs | |
| GCN Sequence Number | 004664 |
| GCN Sequence Number Description | metaxalone TABLET 400 MG ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 17920 |
| HICL Sequence Number | 001945 |
| HICL Sequence Number Description | METAXALONE |
| Brand/Generic | Generic |
| Proprietary Name | Metaxalone |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Metaxalone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 400 |
| Active Ingredient Units | mg/1 |
| Substance Name | METAXALONE |
| Labeler Name | CIPLA USA INC. |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207466 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69097-0998-07 (69097099807)
| NDC Package Code | 69097-998-07 |
|---|---|
| Billing NDC | 69097099807 |
| Package | 100 TABLET in 1 BOTTLE (69097-998-07) |
| Marketing Start Date | 2023-06-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |